OB/GYN providers often serve a primary care role for their patients, creating an entry point to many other women’s health specialties like maternal-fetal medicine, pelvic floor care, menopause treatment, Botox injections, weight management, advanced fertility treatments, and mental health care.

These wide-ranging services continue to benefit from several powerful themes, from women having children later in life to a lack of OB/GYN care access in certain geographies to a greater emphasis on preventative care.

“OB/GYN is a large total addressable market that has attracted investor attention,” says Andy Dixon, a managing director in our Healthcare & Life Sciences Group. “Leading companies in the space are offering a broader suite of in-demand services while establishing more coordinated care for women.”

“An expansive ecosystem of local and regional practices creates opportunities for M&A investors to execute this strategy and build sophisticated, scaled platforms that deliver better care to patients,” adds Geoff Smith, a managing director in our Healthcare & Life Sciences Group.

In our new OB/GYN report, our senior professionals explore:

• The market’s key growth drivers

• Complementary OB/GYN services

• The current sector landscape

To further discuss OB/GYN’s M&A potential, please contact our senior professionals.